← Home
/
Cellectar Biosciences, Inc. (CLRB)
Stock Analysis
Cellectar Biosciences, Inc. (CLRB)
CLRB
CLRB · Market data
2.49
+0.40%
Updated: 2026-06-18 17:28 UTC
WOI Investment Thesis
Vulnerable
Watch confirmation and invalidation levels before acting.
✓
Fundamentals
Insufficient / Insufficient
✓
Price Structure
Vulnerable
×
Breakout Confirmation
Pending
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
—
↗
Break Above
Confirmation improves above resistance.
2.79
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below —
What's Driving CLRB?
📈 Technical recovery is improving
Momentum is Neutral. Watch 2.79 for confirmation and — for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
Breakout Watch
Downtrend line not broken yet · score 0
Business Lens
Financial context is mixed
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
↗
Revenue Growth
Insufficient
●
Profitability
Insufficient
📈 Net Income
-5.65M
≈ Insufficient
🧮 EPS (Basic)
-1.33
≈ Insufficient
Cellectar Biosciences, Inc.
Note: This is an algorithmic technical snapshot, not financial advice.